News from the FDA/CDC

COVID-19: Medicare data show long hospital stays, disparities


 

Half of all COVID-19 hospitalizations among Medicare beneficiaries last 8 days or longer, according to a new analysis by the Centers for Medicare & Medicaid Services.

Distribution of COVID-19 hospitalizations by length of stay

CMS encounter and claims data show almost 110,000 hospital stays for COVID-19 from Jan. 1 to May 16, 2020. Of the longer admissions, 18% were 8-10 days, 16% were 11-15 days, and another 16% were 16 days or longer, the CMS reported in a preliminary data snapshot released June 22.

The hospitalization rate for the Medicare population was 175 per 100,000 as of May 16, but the CMS data show a number of disparities involving race/ethnicity and other demographic characteristics were uncovered, such as the following:

  • Black patients were hospitalized for COVID-19 at a much higher rate, at 465 per 100,000 beneficiaries, than were Hispanics (258), Asians (187), and whites (123).
  • Residents of urban/suburban areas had a much higher hospitalization rate than did those living in rural areas: 205 versus 57 per 100,000.
  • Beneficiaries enrolled in both Medicare and Medicaid had 473 hospitalizations per 100,000, but the rate for those with Medicare only was 112.

“The disparities in the data reflect longstanding challenges facing minority communities and low-income older adults, many of whom face structural challenges to their health that go far beyond what is traditionally considered ‘medical,’ ” CMS Administrator Seema Verma said in a separate statement.

Recommended Reading

Lung ultrasound works well in children with COVID-19
MDedge Dermatology
The evolution of “COVIDists”
MDedge Dermatology
After the ICU: A ‘fraternity of people who are struggling’
MDedge Dermatology
Where does dexamethasone fit in with diabetic ketoacidosis in COVID-19?
MDedge Dermatology
Daily Recap: Headache as COVID evolution predictor; psoriasis drug treats canker sores
MDedge Dermatology
Experts publish imaging recommendations for pediatric COVID-19
MDedge Dermatology
Cortisol levels on COVID-19 admission may be a marker of severity
MDedge Dermatology
ACR issues guidances for MIS-C and pediatric rheumatic disease during pandemic
MDedge Dermatology
Guidance on infection prevention for health care personnel
MDedge Dermatology
Inside Mercy’s mission to care for non-COVID patients in Los Angeles
MDedge Dermatology